PharmacoGENEtics in Youth Depression (GENE-YD) Study protocol: a pilot triple-blinded randomised controlled trial using pharmacogenetics to tailor antidepressant treatment in young Australians

Background The prevalence of depression and mood disorders has been steadily rising in Australian youth, with a concomitant increase in antidepressant pharmacotherapy prescription rates. Yet, the tolerability and efficacy of antidepressant drugs in youth remain poor. Pharmacogenetic (PGx) testing, o...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Svetlana Baltic, Bradley Roberts, Zahra Cooper, Aleksandra Miljevic, Susanne H Stanley, Bernadette T Majda, Khan R L Collins, Suzanna E Lindsey-Temple, P Anthony Akkari, Sean D Hood, Jennifer Rodger
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2025-11-01
Rangatū:	BMJ Open
Urunga tuihono:	https://bmjopen.bmj.com/content/15/11/e103644.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!